How We Score: Our Comparison Methodology
Prices verified May 22, 2026 · Updated for 2026
We score every provider on five weighted criteria: pricing transparency (30%), clinical oversight (25%), pharmacy quality (20%), user experience (15%), and format options (10%). No provider pays for placement. We disclose every affiliate relationship. This page is our accountability contract with you.
Why we publish this
Every other GLP-1 comparison site is either a provider ranking itself first or an affiliate site with no transparency about how rankings are determined. We think that's a problem. If you're trusting a website to help you choose a medication, you deserve to know exactly how that website makes its decisions—and its money.
This page explains both.
The five scoring criteria
Every provider we evaluate is scored on a 100-point scale across five categories. The weights reflect what matters most to cash-pay patients researching GLP-1 options online.
| Criterion | Weight | What we measure |
|---|---|---|
| Pricing Transparency | 30% | Is the advertised price the actual total monthly cost? Are there hidden membership fees, dose-based price jumps, or undisclosed shipping charges? We calculate Total Monthly Cost (TMC): medication + membership + consult + shipping. |
| Clinical Oversight | 25% | Is there a real medical evaluation before prescribing? Are providers licensed and identifiable? Is there ongoing clinical follow-up, or is it a one-and-done prescription mill? |
| Pharmacy Quality | 20% | Does the provider disclose its pharmacy partner? Is it a 503A or 503B facility? LegitScript verified? Are there third-party testing or quality certifications? |
| User Experience | 15% | How fast is onboarding? Is the website clear? Is customer support responsive? Do patients report positive experiences in verified reviews? |
| Format Options | 10% | Does the provider offer both semaglutide and tirzepatide? Injectable and oral? Multiple dose levels? More options means better fit for more patients. |
How we collect data
We verify pricing by going through each provider's signup flow at least once per month. We screenshot pricing pages, record any fees disclosed during checkout, and document the total cost at standard doses (semaglutide 0.5mg and 1.0mg, tirzepatide 5mg and 10mg). If a provider's pricing differs from what we recorded, we update within 48 hours of verification.
Clinical and pharmacy information comes from provider websites, SEC filings where applicable, state board of pharmacy records, and LegitScript's verification database. We do not rely on provider self-reporting alone.
User experience data comes from verified review platforms (Trustpilot, Google Reviews, BBB), patient forums, and our own signup testing. We weight verified purchases more heavily than unverified reviews.
What "Editor's Pick" and "Best Value" mean
Editor's Pick is the provider we'd recommend to a friend who asked "which one should I try first?" It's the best combination of low barrier to entry, clinical quality, and overall value. It does not go to the highest-paying affiliate.
Best Value is the lowest verified Total Monthly Cost from a provider that meets our minimum thresholds for clinical oversight and pharmacy quality. Cheap alone doesn't qualify—cheap and safe does.
Budget Pick is the most affordable entry point for patients who need to minimize upfront cost.
How we make money
Compare GLP-1 earns affiliate commissions when you sign up for a provider through our links. This means if you click a link on our site and later become a customer, we may receive a payment from that provider's affiliate program.
Here's what this does not mean:
- Providers do not pay us to be listed. Every provider on our comparison table is there because it meets our quality thresholds.
- Higher-paying affiliates do not automatically rank higher. Our #1 pick (Embody, $400 CPA) pays less than our highest-CPA partner.
- We do not suppress negative information about affiliate partners. If a provider has an FDA warning letter, we disclose it—even if they pay us commissions.
Every affiliate link on this site is marked with "Paid link" and uses rel="sponsored noopener" per FTC guidelines. The affiliate disclosure bar at the top of every page links back to this methodology.
What we won't do
- Fabricate pricing. If we can't verify a price, we say "check provider" instead of guessing.
- Invent testimonials. Every patient quote on this site links to its verified source.
- Hide conflicts of interest. If a provider is also an advertiser, you'll know.
- Suppress FDA actions. MEDVi received an FDA warning letter in February 2026. We disclose this on every page where MEDVi appears, including this one.
- Promote unsafe products. Providers that fail our pharmacy quality threshold are excluded entirely, regardless of CPA.
Provider-specific disclosures
| Provider | Disclosure |
|---|---|
| MEDVi | Received FDA warning letter (Feb 2026) regarding marketing claims. We include a warning banner on all pages where MEDVi is featured. |
| Sesame Care | Prescribes FDA-approved brand-name medications only (Wegovy, Ozempic, Zepbound). Not a compounded option. |
| Synergy Rx | Deprioritized in our rankings due to pricing concerns relative to comparable providers. |
| GobyMeds | Direct affiliate relationship (not through Katalys network). LegitScript verified, 503A+503B pharmacies. |
How to hold us accountable
If you find a pricing error, a broken link, or a provider we've rated unfairly, email us. We investigate every report and publish corrections with dates. Our credibility depends on accuracy—and we take that seriously.
Related Verdicts
Best GLP-1 Provider Without Insurance →Brand-Name vs. Compounded GLP-1: The Trade-Offs →Sources & References
- FTC Endorsement Guides, 16 CFR Part 255. Updated 2023.
- FDA Warning Letters to GLP-1 Telehealth Companies, 2025–2026.
- LegitScript verification database. Accessed May 2026.
- Provider pricing verified through direct signup flow testing, May 2026.